FMR LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:23 am Purchase | 2026-03-31 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | FMR LLC | 6,787,700 14.800% | 1,933,346 (+39.83%) | Filing |
| 2026-03-06 10:05 am Purchase | 2026-02-27 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | FMR LLC | 4,854,354 10.600% | 4,854,354 (New Position) | Filing |